Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.20.1
Segment Information (Details) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Revenues $ 296,956 $ 284,164  
Costs and expenses 254,501 274,157  
Real property operating income 42,455 10,007  
Other operating expenses 3,264,647 4,475,320  
Interest expense 42,169 27,641  
Other income (expense) (6,420) (11,975)  
Total other income (expense) (48,589) (39,616)  
Net loss (3,270,781) (4,504,929)  
Identifiable long-lived tangible assets 8,250,005   $ 8,337,105
Real property operations [Member]      
Revenues 296,956 266,626  
Costs and expenses 254,501 230,759  
Other operating expenses 110,816 109,906  
Interest expense 24,658  
Other income (expense) (935) 8  
Net loss 69,296 98,689  
Identifiable long-lived tangible assets 7,709,622   7,750,743
Medical related consulting services - related parties [Member]      
Revenues 14,260  
Costs and expenses 13,091  
Other operating expenses 155,235 179,128  
Other income (expense) (5,487) (12,111)  
Net loss 160,722 190,070  
Identifiable long-lived tangible assets 245,763   263,621
Corporate/Other [Member]      
Other operating expenses 2,962,597 3,965,405  
Interest expense 42,169 2,983  
Net loss 3,004,766 3,968,388  
Development services and sales of developed products [Member]      
Revenues 3,278  
Costs and expenses 30,307  
Other operating expenses 35,999 220,881  
Other income (expense) 2 128  
Net loss 35,997 247,782  
Identifiable long-lived tangible assets 294,620   $ 322,741
Gross profit from medical related consulting services [Member]      
Real property operating income 1,169  
Gross (loss) profit from development services and sales of developed products [Member]      
Real property operating income (27,029)  
Gross profit from Real Property Operating [Member]      
Real property operating income $ 42,455 $ 35,867